Remitly Appoints Ronit Peled as Chief People Officer
SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY), a trusted provider of digital financial services that […]
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches […]
New Providence Acquisition Corp. II Announces Adjournment of Special Meeting of Stockholders
New York, New York, May 07, 2024 (GLOBE NEWSWIRE) — New Providence Acquisition Corp. II (Nasdaq: NPAB) (the “Company”) announced […]
Heritage Bank of Commerce Named One of Forbes 2024 World’s Best Banks
SAN JOSE, Calif., May 07, 2024 (GLOBE NEWSWIRE) — Heritage Commerce Corp (NASDAQ: HTBK) (the “Company”) announced that Heritage Bank […]
IZEA Announces Return of AI Days at Cannes
ORLANDO, Fla., May 07, 2024 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of technology, data, and […]
Capital Bank Welcomes Jim Witty as Senior Vice President – Director of Contractor Banking
ROCKVILLE, Md., May 07, 2024 (GLOBE NEWSWIRE) — Capital Bank (NASDAQ: CBNK), a prominent financial institution serving the DC Metro […]
Texas Capital Foundation Announces Second Annual Honors Awards Grant Recipients
DALLAS, May 07, 2024 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today […]
Teknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy Development
First-of-its-kind custom configurator – available today – gives scientists access to high quality, customizable buffers in small volumes for use […]
FibroBiologics to Present at the BIO International Convention 2024
HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 150+ patents issued […]
Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock
– Conversions Eliminate All Variable Priced Derivative Securities – Conversions Eliminate Any Market Overhang from Warrants – Series A Preferred […]
